Genesys Capital invests in high-growth sectors like biotechnology, pharmaceuticals, and medical technology. With a proven track record of transforming emerging bioscience opportunities into successful companies, Genesys has generated over 18 exits from 38 portfolio companies and invested more than $250M. Backed by strong industry relationships and deep life sciences expertise, Genesys is actively considering new, high-potential life science companies for investment.